Inpharma Weekly

, Volume 983, Issue 1, pp 21–21 | Cite as

Patients prefer IV to SC immunoglobulins

Newsletter Article


Adverse Effect Primary Antibody Venous Access Serum Immunoglobulin Infusion Site 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1995

Personalised recommendations